One year into the second Trump administration, we have seen a continuation of some evergreen enforcement priorities as well as new fonts of potential risk and exposure. As in years past, the investigation and prosecution of health care fraud cases remains at the forefront of the federal government’s enforcement activity, though tempered by the government’s interest in a variety of non-health care enforcement, some of which we take up in forthcoming entries in our Year in Preview series.